Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Coins2Day 500
    • Coins2Day 500
    • Coins2Day 500 U.S.
    • Coins2Day Global 500
    • Coins2Day 500 Europe
    • Coins2Day China 500
    • Coins2Day SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Ebola vaccine

Ebola vaccine

Vials of AstraZeneca's Covid-19 vaccine.
Health

With AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries

By Jeremy Kahn
October 2, 2020
Merck Ebola Vaccine Approved
Newsletters

Merck Wins European Approval for World’s First-Ever Ebola Vaccine

By Sy Mukherjee
November 11, 2019
DR Congo ebola outbreak

DR Congo’s Ebola Virus Outbreak Is Six Months Old and Spreading. Here’s Why

By Brittany Shoot
February 4, 2019
DRCONGO-HEALTH-EBOLA-VACCINATION
Health

More Merck Vaccines Are Headed to Eastern Congo Following New Ebola Outbreak

By Lucas Laursen
August 6, 2018
Brazil Faces New Health Epidemic As Mosquito-Borne Zika Virus Spreads Rapidly
Tech

A New Approach to Fighting Viruses Shows Promising Early Results

By David Z. Morris
May 14, 2016
Bomb downed plane in Egypt, says Russian security chief
International

Putin Says Russia Has Developed an Ebola Vaccine

By TIME
January 14, 2016
ArcelorMittal facility
International

Merck buys the rights to an experimental Ebola vaccine

By Reuters
November 24, 2014
UN Foundation CEO on 3 untold Ebola stories
MPW

UN Foundation CEO on 3 untold Ebola stories

By Caroline Fairchild
October 17, 2014
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
International

Funding cuts delayed Ebola vaccine, U.S. official says

By TIME
October 13, 2014

Most Popular

  • North America
    'I meant what I said in Davos': Carney says he really is planning a Canada split with the U.S. along with 12 new trade...
    By Rob Gillies and The Associated Press
  • Politics
    The American taxpayer spent nearly half a billion dollars deploying federal troops to U.S. cities in 2025, CBO finds
    By Nick Lichtenberg
  • Economy
    Right before Trump named Warsh to lead the Fed, Powell seemed to respond to some of his biggest complaints about the...
    By Jason Ma
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Coins2Day
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.